Conemaugh Miners Medical Center Named Screening Center of Excellence by GO2 Foundation for Lung Cancer

Conemaugh Miners Medical Center has been named a Screening Center of Excellence by the GO2 Foundation for Lung Cancer for its ongoing commitment to responsible lung cancer screening. Low dose CT screening for lung cancer carried out safely, efficiently and equitably can save tens of thousands of lives a year by finding lung cancer early when it is most treatable and even curable.

“Conemaugh Miners Medical Center is dedicated to providing patients with the highest quality care. Low dose CT screening has shown to be the only proven method to detect lung cancer at an early and treatable stage. We are thrilled to be part of this elite group, setting an example for responsible screening practices across the country,” said Tim Harclerode, CEO, Conemaugh Miners Medical Center.

Designated Screening Centers of Excellence are committed to provide clear information on who is a candidate for lung cancer screening based on current evidence and to comply with comprehensive standards reflecting best practices developed by professional bodies such as the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN) and the International Early Lung Cancer Action Program (I-ELCAP). Through established guidelines for controlling screening quality, radiation dose and diagnostic procedures within an experienced, multi-disciplinary clinical setting, Screening Centers of Excellence are ensuring that lung cancer screening’s life-saving benefit transforms lung cancer care in their local community.

“We are proud and honored to be working with Conemaugh Miners Medical Center as a GO2 Foundation for Lung Cancer Screening Center of Excellence. Their commitment to practice responsible lung cancer screening will lead to advancements in research and many lives saved. They are an example to follow,” said GO2 Foundation Co-Founder, President and CEO, Laurie Fenton Ambrose.